Sharp declines in circulation of enveloped respiratory viruses have been described globally,
1-9 including in the US, in temporal association with the COVID-19 pandemic and nonpharmaceutical interventions (eg, masking, social distancing, and handwashing).
10-13 Despite these interventions, rhinoviruses (ie, nonenveloped viruses that are sometimes combined with enteroviruses and reported as rhinoviruses and/or enteroviruses because of molecular cross-reactivity between the 2 groups) were not affected as substantially,
1-8,10-12 although enterovirus D68 circulation was lower than anticipated in the fall of 2020.
14 Continued circulation of rhinoviruses (or rhinovirus and/or enterovirus) has been attributed to viral stability; the possible role of asymptomatic transmission; and/or the relative contribution of different transmission mechanisms, such aerosol, droplet, or contact.
1-8,10-12 However, these previous reports describing rhinovirus (or rhinovirus and/or enterovirus) circulation during the pandemic were restricted to the fall of 2020,
4,5,7-9 were among heterogeneous populations (unspecific to age group and/or health care setting),
4-7,9-12 or had limited clinical descriptions.
1-12 Therefore, in this cross-sectional study, we aimed to quantify and characterize rhinovirus and/or enterovirus detection across multiple years before and during the COVID-19 pandemic among children and adolescents seeking medical care for acute respiratory illness (ARI) at emergency departments (EDs) or hospitals within the New Vaccine Surveillance Network (NVSN) in the US.